Journal profile · ALLERGYIMMUNOLOGY-IMMUNOLOGY
Journal of Allergy and Clinical Immunology-In Practice
ISSN 2213-2198 · eISSN 2213-2201 · Elsevier · NETHERLANDS
Journal of Allergy and Clinical Immunology-In Practice: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 7.1; hybrid open access; APC about USD 4,000; median 105 days to acceptance (107 articles, last 24 months); acceptance rate 28% (journal website); 638 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Allergy and Clinical Immunology-In Practice is published by Elsevier and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Asthma and respiratory diseases, Food Allergy and Anaphylaxis Research and Allergic Rhinitis and Sensitization, together about 38.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
JACI: In Practice is an official publication of the American Academy of Allergy, Asthma & Immunology (AAAAI), and a companion title to the field-leading The Journal of Allergy and Clinical Immunology. It brings timely clinical papers, instructive case reports, and the latest management recommendations to clinical allergists and other physicians concerned with clinical manifestations of allergic and immunologic diseases in their practice.Vision The vision of JACI: In Practice is to be an indispensable resource for clinicians who manage patients with asthma, allergic, immunologic, and related conditions in order to optimize the care and health of these patients.Mission The mission of JACI: In Practice is to provide novel, valid, generalizable, and impactful information to support evidence-based clinical decisions in the diagnosis and management of asthma, allergic, immunologic, and related conditions.AAAAI Journals Diversity Statement Equity and inclusion in publishing are critically important for scientific innovation and excellence. The AAAAI Journals value inclusion and diversity across research, through its various lenses, be it authors, reviewers, or editors. This is in line with the AAAAI Diversity Equity and Inclusion Statement as well as Elsevier's support of the joint commitment for action on inclusion and diversity in publishing. We are committed to multilevel initiatives to promote diversity, equity, and inclusion in the articles we publish and in the people who write, review, and edit them.Scope JACI: In Practice publishes clinically impactful articles on the spectrum of conditions treated by allergist-immunologists in their practice: food allergy, respiratory disorders (including asthma, allergic and nonallergic rhinitis/rhinoconjunctivitis, nasal polyps, chronic sinusitis, cough, allergic bronchopulmonary aspergillosis [ABPA], and hypersensitivity pneumonitis), drug allergy, insect sting allergy, anaphylaxis, dermatologic disorders (including atopic dermatitis, contact dermatitis, urticaria, angioedema, and hereditary angioedema [HAE]), immunodeficiency, autoinflammatory syndromes, eosinophilic disorders, and mast cell disorders. The Journal emphasizes cutting edge practical clinical information for practitioners that they can use in everyday practice or will help them acquire new knowledge or skills they can directly apply to patient care. Mechanistic or translational studies without immediate or near future clinical relevance and animal studies are not within the scope of the Journal.Content All JACI: In Practice content is peer-reviewed. The Journal welcomes original research articles that fit into the above scope. For each Original Article, a highlight box indicates what is already known about this subject, what this study adds, and how the new information impacts current management guidelines. Shorter original research and instructive case reports are presented as Clinical Communications. "Images in Allergy" articles consist of clinical pictures (eg, X-rays, CT scans, biopsies, allergens, endoscopic visualizations of the airway, eruptions, etc.) and impart important clinical information. In addition, JACI: In Practice features various types of review articles that will primarily be invited by the editors. Many of these offer CME, and the invited Difficult Cases feature offers MOC credit. The original and review articles are supplemented by Editorials, AAAAI Practice Papers, Practice Options From Beyond Our Pages, Ask the Expert, and Practice Pearls features.Contact Us Editorial Office: inpractice@aaaai.org; Tel 720-446-2822 Editorial Manager submission site: https://www.editorialmanager.com/inpractice AAAAI: info@aaaai.org; Tel 414-272-6071
From the journal's Aims & Scope
Research area (LetPub): ALLERGYIMMUNOLOGY-IMMUNOLOGY
Editor-in-chief Michael SchatzPublisher website
Editorial board by country: none in mainland China; most named United States 55, Australia 8, United Kingdom 6, Canada 3, Hong Kong, China 2 (90 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Asthma and respiratory diseasesMedicine16.4%
- Food Allergy and Anaphylaxis ResearchMedicine12.4%
- Allergic Rhinitis and SensitizationMedicine9.4%
- Drug-Induced Adverse ReactionsMedicine8%
- Contact Dermatitis and AllergiesMedicine5.2%
- Respiratory and Cough-Related ResearchMedicine4.8%
- Urticaria and Related ConditionsMedicine4.7%
- Eosinophilic EsophagitisMedicine4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Immunology | Zone 1 |
| Minor | Allergy | Zone 2 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Allergy | Zone 1 |
| Minor | Immunology | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Allergy | Zone 1 |
| Minor | Immunology | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 7.1LetPub ·
- Impact factor (publisher)
- 7.2Publisher website ·
- CiteScore 2026-06
- 9.6LetPub ·
- CiteScore (publisher)
- 9.6Publisher website ·
- SJR 2026-06
- 1.77LetPub ·
- SNIP 2026-06
- 1.65LetPub ·
- h-index
- 40LetPub ·
- h-index
- 137OpenAlex ·
- i10-index
- 3,048OpenAlex ·
- 2-year mean citedness
- 3.81OpenAlex ·
- Self-citation rate
- 11.1%LetPub ·
- Share of gold OA articles
- 21.64%LetPub ·
Volume
- Articles per year
- 288LetPub ·
Articles by year OpenAlex count · 7,475 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 427 | 170 | 193 |
| 2025 | 638 | 311 | 1,911 |
| 2024 | 668 | 306 | 4,507 |
| 2023 | 721 | 402 | 7,333 |
| 2022 | 656 | 353 | 9,528 |
| 2021 | 785 | 419 | 14,993 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
105 daysMedian, submission to acceptance · P25–P75 72 days – 140 days
- Acceptance to online
- median 11 days (94 articles)
- Submission to online
- median 123 days
- Sample
- 107 articles with submission and acceptance dates (1,028 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Acceptance rate (publisher)
- 28%Publisher website ·
- Submission to first decision
- 4 daysPublisher website ·
- First decision after review
- 30 daysPublisher website ·
- Submission to acceptance
- 87 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,000 / EUR 3,740 / GBP 3,200 / JPY 496,120 | — | — | |
| Publisher website | USD 4,000 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 3,500 words
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
- Highlights
- Required
- Graphical abstract
- Optional
Article types accepted6, with length limits
- case studyd be omitted if they are not essential. Case Studies in Health Disparities must: (1) Be no longer than 1000 words. (2) Have no more than two visual elements (ta…main text ≤ 1,000 words
- clinical communicationsB. Clinical Communications. Clinical Communications are brief reports of clinical or laboratory observations or case series.Length not stated
- original articleThe Journal will consider publication of several types of manuscripts:A. Original articles. These articles should describe fully, but as concisely as feasible, …main text ≤ 3,500 words
- original articlesA. Original articles. These articles should describe fully, but as concisely as feasible, the results of original clinical research.Length not stated
- reviewThe Journal will consider publication of several types of manuscripts:A. Original articles. These articles should describe fully, but as concisely as feasible, …Length not stated
- review articleplementation Science The formatting for Review Articles in this feature is as follows: The overall length of the manuscript should be limited to 3000 words (not…main text ≤ 3,000 words
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- AI use Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Authorship
As recommended by the International Committee of Medical Journal Editors (ICMJE) (ICMJE | Recommendations | Defining the Role of Authors and Contributors), in order to be included in the list of authors on a manuscript, an individual must have done all of the following: (1) made substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; (2) dra…
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest
All authors must disclose all financial relationships for themselves and their immediate family/significant others. The Journal requires all authors to acknowledge, on the title page of the manuscript, all funding sources that supported their work and any commercial associations that might pose a conflict of interest. These include consultant arrangements, speakers' bureau participation, stock or …
Source ↗Publisher website ·- Data availability Data sharing author instructions statement
Data sharing supported; authors encouraged to archive data in public repository and provide data availability statement. Model summary
JACI: In Practice supports data sharing. Authors are encouraged to archive data in an appropriate public repository. Authors may provide a data availability statement with their submission, including a link to the repository they have used, to be published in their article. This statement should be included on the title page of the manuscript. Anyone using these shared data should cite the origina…
Source ↗Publisher website ·- Publication ethics
Tobacco industry funding policy: studies funded by tobacco industry not considered. Model summary
The AAAAI journals will not consider studies or articles funded by the tobacco industry or by organizations that receive substantial funding from the tobacco industry.
Source ↗Publisher website ·- License & copyright Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement. Subscribers may reproduce tables of contents or prepare lists of articles inclu…
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Peer review Peer Review Process
Peer review model: single-blind. Model summary
All manuscripts are reviewed by at least one editor. Manuscripts may be rejected by the editor(s) without peer review due to being out of the journal scope or if they are determined to be low priority based on considerations such as novelty, validity, generalizability, and clinical impact. Manuscripts warranting further consideration are sent for peer review. Most manuscript are evaluated by at le…
Source ↗Publisher website ·- Plagiarism
Originality screening via Crossref Similarity Check. Model summary
To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.
Source ↗Publisher website ·- Preprints Preprints
Preprint policy: preprint posting allowed; must be updated with link to final published version upon publication. Model summary
JACI: In Practice allows submissions that have been posted on preprint servers. Upon publication in our journal, authors are required to update their preprint article with a link to the final published version.Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If a preprint is used as a reference, it should be …
Source ↗Publisher website ·- Trial registration / reporting guidelines PRISMA guidelines for systematic reviews and meta-analyses
For meta-analysis of RCTs, we encourage authors to consult the recommendations of the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement, available at www.prisma-statement.org.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- NETHERLANDS
- Language
- English
- ISSN
- 2213-2198
- Electronic ISSN
- 2213-2201
- Society / sponsor
- American Academy of Allergy
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Allergy and Clinical Immunology-In Practice
What CAS zone is Journal of Allergy and Clinical Immunology-In Practice in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Allergy and Clinical Immunology-In Practice is in Zone 1 of Medicine, and in Zone 1 of the minor category Immunology / Allergy; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Allergy and Clinical Immunology-In Practice?
The latest impact factor listed by LetPub is 7.1; CiteScore 9.6, h-index 137.
How long does peer review take at Journal of Allergy and Clinical Immunology-In Practice?
Based on the dates recorded on 107 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 105 days (interquartile range 72–140 days); the journal's website gives an acceptance rate of 28%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Allergy and Clinical Immunology-In Practice?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 3,500 words; Reference style: Vancouver; First submission: Free format: the journal's layout is not required; Highlights: Required; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Allergy and Clinical Immunology-In Practice based?
Of the 90 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (55), Australia (8) and United Kingdom (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Allergy and Clinical Immunology-In Practice?
According to LetPub and DOAJ records, Journal of Allergy and Clinical Immunology-In Practice is indexed in SCIE and Scopus.
Is Journal of Allergy and Clinical Immunology-In Practice open access, and what is the APC?
Journal of Allergy and Clinical Immunology-In Practice is a hybrid journal. For open-access publication: APC about USD 4,000.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .